Evidence map›Paper›PMID 40951685›Full record

ArticleCanadian journal of kidney health and disease2025

Non-steroidal Anti-inflammatory Drug Prescriptions in Living Kidney Donors: A Retrospective Cohort Study.

Mikayla I Laube, Robert R Quinn, Pietro Ravani, Krista L Lentine, Alix Clarke, Rachel Jeong, Jason Bau, Ngan N Lam

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mikayla I LaubeDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.
Robert R QuinnDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0001-5672-9368
Pietro RavaniDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0001-6973-8570
Krista L LentineCenter for Abdominal Transplantation, Saint Louis University, MO, USA.
Alix ClarkeDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0001-9635-2702
Rachel JeongDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.
Jason BauDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.
Ngan N LamDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0002-0129-7091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Current guidelines recommend that living kidney donors should avoid non-steroidal anti-inflammatory drugs due to their potential nephrotoxic effects. It is unclear if physicians are adhering to this recommendation. Objective: Our aim was to determine the proportion of living kidney donors that filled a non-steroidal anti-inflammatory drug prescription post-donation and the proportion with measurement of kidney function post-prescription. Design: We conducted a population-based, retrospective cohort study. Setting: We identified kidney donors in Alberta, Canada that had accessed the healthcare system in the outpatient, emergency department, or inpatient setting. Patients: Adult living kidney donors in Alberta, Canada who donated between 2002 and 2019. Measurements: We measured the number of non-steroidal anti-inflammatory drug prescriptions, type of prescribing physician, and evidence of post-prescription measurement of creatinine and potassium. Methods: We identified the proportion of donors who filled a non-steroidal anti-inflammatory drug prescription at least 1 year post-donation. We also assessed how many donors underwent laboratory testing for kidney function and potassium within 14 days following the first prescription. Results: Of the 759 living kidney donors included in our study, 273 (36%) had at least one non-steroidal anti-inflammatory drug prescription over a median follow-up of 7.2 years (interquartile range 3.5-11.5). The proportion of donors with at least one prescription in follow-up remained stable over time (~10% per year). Family physicians accounted for 66% of all non-steroidal anti-inflammatory drug prescriptions. Approximately, 10% of donors had measurements of serum creatinine or potassium post-prescription. Limitations: This study was limited by the inability to capture over-the-counter non-steroidal anti-inflammatory drug use, indication for the prescriptions, and indication for bloodwork being completed in the post-prescription period. Conclusions: Over one-third of living kidney donors are prescribed non-steroidal anti-inflammatory drugs despite current guideline recommendations, with only a minority undergoing post-prescription laboratory testing. Further research assessing outcomes following non-steroidal anti-inflammatory drug use is recommended to better inform optimal pain-management strategies for living kidney donors.

Indexed as

bloodworkkidney donationmonitoringnon-steroidal anti-inflammatory drugsprescription

Identifiers

PMID40951685
PMCPMC12432322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.